Topic: clinical research collaboration
C4 Therapeutics has poached a new CMO to help carry its targeted protein degraders closer to the clinic through collabs with Biogen, Calico and Roche.
Purdue Pharma’s new R&D subsidiary, Imbrium Therapeutics, tapped TetraGenetics and its antibody discovery platform for non-opioid-based painkillers.
Celgene signed on for about $1 billion for a Canadian preclinical asset: a small molecule targeting protein-protein interactions in blood cancers.
Basilea Pharmaceutica will collaborate with its fellow Basel-based biotech, Roche, to test a combination immunotherapy in advanced urothelial cancer.
Gamida Cell brought on a subsidiary of the National Marrow Donor Program to support a phase 3 study of its blood cancer cell therapy alternative.
Join as Diane Hayes, PHD, InCrowd President and Co-founder, reviews the results from the 2019 physician predictions survey and considers the year ahead.
Owkin has unveiled what it calls the world’s largest network for artificial intelligence-based medical research, with data from over 40 institutions.
LEO Pharma signed on to a research collaboration with PellePharm that commits up to $760 million for late-stage trials, including a merger option.
After posting sinking response rates, Nektar unveiled new results for its NKTR-214 and Opdivo melanoma therapy that showed rates holding just steady.
TP Therapeutics and Almac will collaborate on a pan-cancer companion diagnostic for TP’s repotrectinib aimed at drug-resistant tumors.